This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2019
EAU 2019
Prostate Cancer
Bladder Cancer
Kidney Cancer
UTUC
Endourology
Testicular and Penile Cancer
EAU 2019 Bladder Cancer
Viewing 1-20 of 33 articles
EAU 2019: TERT Promoter and FGFR3 Mutations – A Highly Sensitive and Non-invasive Tool for Bladder Cancer Recurrence Detection
EAU 2019: Definition of a Structured Training Curriculum for Robot-Assisted Radical Cystectomy: A Delphi-Consensus Study Led by the ERUS Educational Board
EAU 2019: The iROC trial: An RCT Comparing Intracorporeal Robot-Assisted vs Open Radical Cystectomy for Bladder Cancer
EAU 2019: Healthy Male Patient Undergoing Radical Cystectomy, Undecided on Diversion: Open
EAU 2019: Healthy Male Patient Undergoing Radical Cystectomy, Undecided on Diversion: Robotic
EAU 2019: Prediction of Muscle Invasive Bladder Cancer Using the Vesical Imaging-Reporting and Data System and Apparent Diffusion Coefficient Values (VI-RADS/ADC)
EAU 2019: What Can We Expect from Trimodal Therapy - Case-Based Debate No Evidence of Disease After Neoadjuvant Chemotherapy for MIBC: What Next?
EAU 2019: Latest News in Medical Treatment in Onco-Urology: Urothelial Carcinoma
EAU 2019: Survival Differences Between Men and Women with Bladder Cancer Depend Strongly On Time Since Diagnosis
EAU 2019: Blue Light Flexible Cystoscopy – Improving the Patient Experience
EAU 2019: Development and External Validation of the Hematuria Cancer Risk Score to Identify Patient at Risk of Harboring Cancer
EAU 2019: The Impact of Hormones and Reproductive Factors on the Risk of Bladder Cancer in Women: Results from Nurses’ Health Study and Nurses’ Health Study II
EAU 2019: What Can We Expect from Imaging - Case-Based Debate No Evidence of Disease After Neoadjuvant Chemotherapy for MIBC: What Next?
EAU 2019: Cystectomy: Case-based Debate No Evidence of Disease after Neoadjuvant Chemotherapy for MIBC: What next?
EAU 2019: The "Ten Commandments" of Intracorporeal Ileal Conduit During Robot-Assisted Radical Cystectomy
EAU 2019: Fertility in the Young Female Patient with Bladder Cancer – Pregnancy and Fertility: What Do You Need to Know?
EAU 2019: Case-Based Debate: Ileal Conduit or Continent Diversion: Which is a Better Choice for Most Patients?
EAU 2019: Molecular Aspects in Young Patients with Urothelial Carcinoma
EAU 2019: Total Retroperitoneoscopic Nephroureterectomy with Modified Pluck Technique: Initial Experience
EAU 2019: Systemic Treatment for a 2-cm PET Avid Lung Nodule, One Year After Cystectomy, a Case-Based Debate
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free